BACKGROUND: Ion channels and transporters are potential markers and therapeutic targets for several cancers. However, their expression during hepatocellular carcinoma (HCC) development remains unclear. AIM: To investigate the mRNA expression of Na(+), K(+) and Ca(2+) channels and ABC transporters during rat HCC development, as well as Abcc3 protein in human liver biopsies. METHODS: Wistar rats were treated with diethylnitrosamine (DEN) and developed both cirrhosis (12 weeks of treatment) and either pre-neoplastic lesions (16 weeks of treatment) or multinodular HCC (16 weeks of treatment plus 2 weeks DEN-free). The mRNA expression of 12 ion channels and two ABC transporters was studied using real-time RT-PCR. Tumor-containing or tumor-free liver sections were isolated by laser-capture microdissection. Abcc3 protein expression was studied by immunohistochemistry in healthy, cirrhotic and HCC human biopsies. RESULTS: We observed expression changes in seven genes. Kcna3, Kcnn4, Kcnrg and Kcnj11 potassium channel mRNA expression reached peak values at the end of DEN treatment, while Scn2a1 sodium channel, Trpc6 calcium channel and Abcc3 transporter mRNA expression reached their highest levels in the presence of HCC (18 weeks). Whereas Kcnn4 and Scn2a1 channel expression was similar in non-tumor and tumor tissue, the Abcc3 transporter and Kcna3 potassium channels were preferentially overexpressed in the tumor sections. We observed differential Abcc3 protein subcellular localization and expression in human samples. CONCLUSIONS: The ion channel/transporter expression profile observed suggests that these genes are potential early markers or therapeutic targets of HCC. The differential localization of Abcc3 may be useful in the diagnosis of cirrhosis and HCC.
BACKGROUND: Ion channels and transporters are potential markers and therapeutic targets for several cancers. However, their expression during hepatocellular carcinoma (HCC) development remains unclear. AIM: To investigate the mRNA expression of Na(+), K(+) and Ca(2+) channels and ABC transporters during rat HCC development, as well as Abcc3 protein in human liver biopsies. METHODS:Wistar rats were treated with diethylnitrosamine (DEN) and developed both cirrhosis (12 weeks of treatment) and either pre-neoplastic lesions (16 weeks of treatment) or multinodular HCC (16 weeks of treatment plus 2 weeks DEN-free). The mRNA expression of 12 ion channels and two ABC transporters was studied using real-time RT-PCR. Tumor-containing or tumor-free liver sections were isolated by laser-capture microdissection. Abcc3 protein expression was studied by immunohistochemistry in healthy, cirrhotic and HCC human biopsies. RESULTS: We observed expression changes in seven genes. Kcna3, Kcnn4, Kcnrg and Kcnj11 potassium channel mRNA expression reached peak values at the end of DEN treatment, while Scn2a1 sodium channel, Trpc6 calcium channel and Abcc3 transporter mRNA expression reached their highest levels in the presence of HCC (18 weeks). Whereas Kcnn4 and Scn2a1 channel expression was similar in non-tumor and tumor tissue, the Abcc3 transporter and Kcna3 potassium channels were preferentially overexpressed in the tumor sections. We observed differential Abcc3 protein subcellular localization and expression in human samples. CONCLUSIONS: The ion channel/transporter expression profile observed suggests that these genes are potential early markers or therapeutic targets of HCC. The differential localization of Abcc3 may be useful in the diagnosis of cirrhosis and HCC.
Authors: Jung Il Lee; Jin-Woo Lee; Joon Mee Kim; Ja Kyung Kim; Hyun Jung Chung; Young Soo Kim Journal: World J Gastroenterol Date: 2012-09-14 Impact factor: 5.742
Authors: María de Guadalupe Chávez-López; Violeta Zúñiga-García; Julio Isael Pérez-Carreón; Arturo Avalos-Fuentes; Yesenia Escobar; Javier Camacho Journal: Biologics Date: 2016-09-20
Authors: Hugo Jimenez; Minghui Wang; Jacquelyn W Zimmerman; Michael J Pennison; Sambad Sharma; Trevor Surratt; Zhi-Xiang Xu; Ivan Brezovich; Devin Absher; Richard M Myers; Barry DeYoung; David L Caudell; Dongquan Chen; Hui-Wen Lo; Hui-Kuan Lin; Dwayne W Godwin; Michael Olivier; Anand Ghanekar; Kui Chen; Lance D Miller; Yijian Gong; Myles Capstick; Ralph B D'Agostino; Reginald Munden; Philippe Merle; Alexandre Barbault; Arthur W Blackstock; Herbert L Bonkovsky; Guang-Yu Yang; Guangxu Jin; Liang Liu; Wei Zhang; Kounosuke Watabe; Carl F Blackman; Boris C Pasche Journal: EBioMedicine Date: 2019-05-31 Impact factor: 8.143
Authors: Ana Ramírez; Alma Yolanda Vázquez-Sánchez; Natalia Carrión-Robalino; Javier Camacho Journal: Oxid Med Cell Longev Date: 2016-01-05 Impact factor: 6.543